Turner NC, Balmana J, Poncet C, Goulioti T, Tryfonidis K, Honkoop AH, et al. Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study. Here, BRCA1 is linked to breast carcinoma.